Optilight

The First and Only FDA-Approved Light Therapy for Dry Eye Management

OptiLIGHT uses patented Optimal Pulse Technology to deliver precise, controlled light energy that targets inflammation, one of the key underlying factors of dry eye disease due to MGD.

This advanced therapy is designed to safely reach the delicate contours of the treatment area, setting a new standard in dry eye care and offering patients a proven, long-term solution.

A Real Solution for Dry Eyes

Backed by clinical studies, OptiLIGHT uses advanced light-based technology to safely and effectively improve signs of dry eye disease caused by Meibomian Gland Dysfunction (MGD).

OptiLIGHT is designed with patient comfort and precision in mind, delivering controlled light energy to target inflammation and support healthier gland function.

What to expect:

• A typical treatment plan includes four sessions spaced two to four weeks apart

• Each session takes approximately 10 to 15 minutes

• A cooling gel is applied and protective shields are placed over the eyes

• Most patients feel a gentle warming sensation with minimal discomfort

OptiLIGHT treatments are often followed by meibomian gland expression to enhance results and improve tear quality.

Gentle, Fast, No Downtime

Following treatment, you may experience mild redness that usually resolves within a few hours. Most patients return to normal daily activities immediately, including work and makeup application.
Patients are advised to avoid direct sun exposure for a few days and apply sunscreen as recommended.

Many patients begin noticing improvement after their second or third treatment. For best long-term results, maintenance treatments are typically recommended every six to twelve months.